Walleye Trading’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,700
Closed -$245K 5557
2020
Q4
$245K Buy
10,700
+3,600
+51% +$68.5K ﹤0.01% 3346
2020
Q3
$116K Buy
+7,100
New +$129K ﹤0.01% 3330
2019
Q3
Sell
-20,600
Closed -$469K 4576
2019
Q2
$469K Buy
+20,600
New +$556K ﹤0.01% 2243
2018
Q4
Sell
-1,600
Closed -$46K 5561
2018
Q3
$46K Buy
+1,600
New +$48.1K ﹤0.01% 4586

Other funds holding XENT

Walleye Trading's XENT Position: Q4 2020 in Review

Walleye Trading sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 4,233 shares — an estimated $80.6K sold.

Walleye Trading first reported a position in XENT in Q1 2020 and held it in 2 quarters. The position peaked at $289K in Q1 2020. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

  • Walleye Trading reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
  • Walleye Trading sold 4,233 Intersect ENT, Inc shares in Q4 2020, an estimated $80.6K.
  • Walleye Trading first reported a position in Intersect ENT, Inc in Q1 2020 and held it in 2 quarters.
  • Walleye Trading's Intersect ENT, Inc position peaked at $289K in Q1 2020.
  • 110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.